Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 32, Number 12—December 2026
Research Letter
Zoonotic Exposure to Porcine Deltacoronavirus, United States, 2019–2021
Cite This Article
Citation for Media
Abstract
Porcine deltacoronavirus (PDCoV) is a swine coronavirus with zoonotic potential. We detected PDCoV-neutralizing antibodies in 10 of 300 human serum samples; positive sample sources included 1 adult and 9 juveniles. Our findings provide evidence of human exposure to PDCoV and highlight the importance of monitoring animal coronaviruses with zoonotic potential.
Coronaviruses readily cross species barriers, raising concern for human health because of understudied genera such as deltacoronaviruses. Porcine deltacoronavirus (PDCoV) is a globally distributed enteric coronavirus of swine that causes substantial economic losses to the pork industry and has demonstrated the capacity for cross-species infection (1,2). PDCoV uses attachment factors and cellular receptors that are conserved across multiple host species, which can enable cross-species transmission (3–5). In addition, PDCoV infection has been reported in children with swine exposure in Haiti, suggesting zoonotic potential (6).
To assess evidence of human exposure in the United States, we screened 200 commercially acquired adult serum samples collected in 2021 and 100 serum samples obtained from juvenile swine exhibitors participating in agricultural exhibitions during 2019–2021 who reported daily or near-daily contact with swine (Appendix). We tested serum samples by using a whole-virion ELISA optimized for human serum. We evaluated positive results by performing virus neutralization testing. Because validated human positive-control serum samples were unavailable, we used porcine hyperimmune PDCoV serum for assay development and optimization. We tested adult and juvenile serum samples side-by-side by using identical laboratory methods. However, the cohorts differed in age, source population, availability of exposure information, and sample collection history. Pig exposure histories were available for juvenile exhibitors but not for the commercially acquired adult serum samples, precluding direct comparison of swine-contact histories between groups. Juvenile swine exhibitor participation was approved by The Ohio State University institutional review board (protocol no. 2019H0152).
We identified 10 human serum samples that were positive by ELISA (Figure, panels A, B) and capable of neutralizing PDCoV in vitro. One (0.5%) of 200 adult samples and 9 (9.0%) of 100 juvenile exhibitor samples were seropositive. The seropositive adult sample was from a Hispanic female blood donor who was 42 years of age. Positive juvenile samples originated from Oklahoma (n = 3), Florida (n = 3), Ohio (n = 2), and Georgia (n = 1) and were identified in 2020 (n = 5) and 2021 (n = 4). Because of the convenience-based sampling design, uneven geographic representation, and limited pilot dataset, our findings should not be interpreted as evidence of geographic clustering. Juveniles with frequent swine contact had higher odds of seropositivity than adults with undetermined swine contact (odds ratio 19.7 [95% CI 2.5–157]; Fisher exact test p = 0.00028), corresponding to a risk ratio of 18.0 (95% CI 2.6–125) and an absolute risk difference of 8.5% (95% CI 2.8%–14.2%).
All 10 ELISA-positive samples neutralized PDCoV at titers of 1:80–1:320. In contrast, 4 ELISA-negative samples demonstrated no neutralizing activity, whereas 2 ELISA-negative samples neutralized PDCoV at a 1:5 dilution (Table; Appendix Figure 1). ELISA optical density values did not correlate linearly with neutralizing antibody titers, consistent with known differences between binding-antibody assays and functional neutralization assays (7). We evaluated available antiserum against multiple coronaviruses, including porcine epidemic diarrhea virus, transmissible gastroenteritis virus, porcine respiratory coronavirus, bovine coronavirus, human coronavirus NL63, and SARS-CoV-2, and did not identify substantial cross-reactivity in the PDCoV ELISA (Appendix Figure 2). Although antigenic overlap between porcine coronaviruses has been reported (8,9), the detection of PDCoV-neutralizing antibodies strengthens the interpretation that those samples reflect PDCoV exposure.
Our findings provide serologic evidence consistent with human exposure to PDCoV and demonstrate a higher frequency of seropositivity among juveniles with documented swine contact than among adults from the general population. Those observations are consistent with previous reports of PDCoV infection in children in Haiti and with experimental evidence supporting the broad host-range potential of this virus (6). Swine are recognized sources of several zoonotic pathogens, and occupational studies have demonstrated that persons with swine exposure can experience subclinical infection with multiple swine-associated agents (10). However, detection of PDCoV antibodies indicates previous exposure but does not establish active infection, clinical disease, or human-to-human transmission.
The limitations of this study include convenience sampling, limited epidemiologic metadata, and the absence of validated human positive-control samples. Adult and juvenile cohorts were not directly comparable because of differences in demographics, source populations, and available exposure data, and swine-contact histories were unavailable for adult donors. Of consequence, the observed differences in seropositivity should be interpreted cautiously and cannot be used to infer population-level prevalence or transmission risk.
In conclusion, we detected neutralizing antibodies against PDCoV in 10 human serum samples, including 9 from juvenile swine exhibitors with frequent swine contact and 1 from an adult blood donor of unknown swine-exposure status. Those findings provide evidence of human exposure to PDCoV and highlight the importance of monitoring animal coronaviruses with zoonotic potential. Although the public health implications of PDCoV infection in humans are currently unclear, enhanced serologic and virologic surveillance is warranted to determine the extent of spillover, identify risk factors for infection, and evaluate whether PDCoV poses an emerging threat to human health.
Dr. Boley is a biological science laboratory technician with the US Department of Agriculture at the National Bio and Agro-Defense Facility in Manhattan, Kansas, USA. Her research interests include coronaviruses, emerging zoonotic diseases, and chemoprevention of liver cancer.
Acknowledgments
We would like to thank Heather Nicholson and Hannah Cochran for curation of juvenile serum sample library and Marcia Vasquez-Lee for PDCoV technical expertise.
This project was supported, in part, by Agriculture and Food Research Initiative (grant no. 2020-67015-31618) from the United States Department of Agriculture National Institute of Food and Agriculture. Juvenile swine exhibitor serum samples were collected with federal funds from the Centers of Excellence for Influenza Research and Surveillance, National Institute of Allergy and Infectious Diseases, National Institutes of Health, and Department of Health and Human Services (contract no. HHSN272201400006C).
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by P. B. and G.H., S.K., A.B., and J.N. provided oversight and quality assurance to students and research associates. L.S., A.B., and J.N provided reagents, samples, or both. The first draft of the manuscript was written by P.B. and G.H., and all authors revised subsequent versions of the manuscript. All authors read and approved of the final manuscript.
References
- Linhares D, Trevisan G, Cezar G, Magalhães E, Chandra S. Swine disease reporting system report # 64. 2023 Jun 6 [cited 2026 Feb 13]. https://www.swinehealth.org/wp-content/uploads/2023/06/SDRS-report-64.pdf
- Kong F, Wang Q, Kenney SP, Jung K, Vlasova AN, Saif LJ. Porcine deltacoronaviruses: origin, evolution, cross-species transmission and zoonotic potential. Pathogens. 2022;11:79. DOIPubMedGoogle Scholar
- Li W, Hulswit RJG, Kenney SP, Widjaja I, Jung K, Alhamo MA, et al. Broad receptor engagement of an emerging global coronavirus may potentiate its diverse cross-species transmissibility. Proc Natl Acad Sci U S A. 2018;115:E5135–43. DOIPubMedGoogle Scholar
- Yuan Y, Zu S, Zhang Y, Zhao F, Jin X, Hu H. Porcine deltacoronavirus utilizes sialic acid as an attachment receptor and trypsin can influence the binding activity. Viruses. 2021;13:2442. DOIPubMedGoogle Scholar
- Xiao W, Huang W, Chen C, Wang X, Liao S, Xia S, et al. Porcine deltacoronavirus uses heparan sulfate as an attachment receptor. Vet Microbiol. 2023;276:
109616 . DOIPubMedGoogle Scholar - Lednicky JA, Tagliamonte MS, White SK, Elbadry MA, Alam MM, Stephenson CJ, et al. Independent infections of porcine deltacoronavirus among Haitian children. Nature. 2021;600:133–7. DOIPubMedGoogle Scholar
- Bonifacio MA, Laterza R, Vinella A, Schirinzi A, Defilippis M, Di Serio F, et al. Correlation between in vitro neutralization assay and serological tests for protective antibodies detection. Int J Mol Sci. 2022;23:9566. DOIPubMedGoogle Scholar
- Ma Y, Zhang Y, Liang X, Oglesbee M, Krakowka S, Niehaus A, et al. Two-way antigenic cross-reactivity between porcine epidemic diarrhea virus and porcine deltacoronavirus. Vet Microbiol. 2016;186:90–6. DOIPubMedGoogle Scholar
- Gimenez-Lirola LG, Zhang J, Carrillo-Avila JA, Chen Q, Magtoto R, Poonsuk K, et al. Reactivity of porcine epidemic diarrhea virus structural proteins to antibodies against porcine enteric coronaviruses: diagnostic implications. J Clin Microbiol. 2017;55:1426–36. DOIPubMedGoogle Scholar
- Augustyniak A, Pomorska-Mól M. An update in knowledge of pigs as the source of zoonotic pathogens. Animals (Basel). 2023;13:3281. DOIPubMedGoogle Scholar
Figure
Table
Cite This ArticleOriginal Publication Date: November 02, 2026
1Current affiliation: US Department of Agriculture , National Bio and Agro-Defense Facility, Manhattan, Kansas, USA
Table of Contents – Volume 32, Number 12—December 2026
| EID Search Options |
|---|
|
|
|
|
|
|

Please use the form below to submit correspondence to the authors or contact them at the following address:
Scott P. Kenney, Center for Food Animal Health, 1680 Madison Ave, Wooster, OH 44691, USA
Top